Insiders · Profile

Coleman Mark

Director at Axsome Therapeutics. Filing since 19 Mar 2019. CIK 0001658379

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jun 2026
Director
Sold on a plan
643
$160.11K
2.1%
2 Jun 2026
Director
Sold on a plan
5,537
$1.24M
15.8%
1 Jun 2026
Director
Sold on a plan
6,000
$1.38M
14.6%
29 May 2026
Director
Sold on a plan
6,000
$1.40M
12.7%
26 Feb 2026
Director
Sold on a plan
25,000
$4.03M
34.7%
8 Sep 2025
Director
Bought
1,575
$200.47K
3.4%
28 May 2025
Director
Sold on a plan
3,750
$387.86K
7.4%
27 May 2025
Director
Sold on a plan
3,750
$395.51K
6.9%
20 May 2025
Director
Sold at will
3,000
$322.47K
5.3%
29 May 2024
Director
Sold on a plan
5,248
$394.33K
26.4%
28 May 2024
Director
Sold on a plan
5,249
$394.77K
20.9%
15 Sep 2023
Director
Sold on a plan
18,572
$1.40M
4.4%
15 Sep 2023
Director
Sold on a plan
11,016
$828.24K
30.5%
18 Nov 2021
Director
Bought
1,430
$50.18K
0.3%
12 May 2021
Director
Bought
500
$29.08K
0.1%
29 Jun 2020
Director
Bought
650
$51.03K
0.2%
26 Jun 2019
Director
Bought
15,800
$364.98K
2.4%
25 Jun 2019
Director
Bought
400
$9.30K
0.1%
13 May 2019
Director
Bought
4,650
$99.70K
0.7%
19 Mar 2019
Director
Bought
5,100
$62.12K
opened
20 decisions on file.